References
- Cazzola M, MacNee W, Martinez FJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J. 2008;31(2):416-469. doi:10.1183/09031936.00099306
- Quanjer PH, Ruppel GL, Langhammer A, et al. Bronchodilator response in FVC is larger and more relevant than in FEV1 in severe airflow obstruction. Chest 2016;151(5):1088–1098. doi:10.1016/j.chest.2016.12.017
- Cerveri I, Pellegrino R, Dore R, et al. Mechanisms for isolated volume response to a bronchodilator in patients with COPD. J Appl Physiol. 2000;88(6):1989–1995.10846010
- Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–968. doi:10.1183/09031936.05.0003520516264058
- Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.0003480516055882
- Eaton T, Withy S, Garrett JE, Mercer J, Whitlock RM, Rea HH. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest. 1999;116(2):416–423. doi:10.1378/chest.116.2.41610453871
- Allen S, Yeung P, Janczewski M, Siddique N. Predicting inadequate spirometry technique and the use of FEV1/FEV3 as an alternative to FEV1/FVC for patients with mild cognitive impairment. Clin Respir J. 2008;2(4):208–213. doi:10.1111/j.1752-699X.2008.00063.x20298336
- Ioachimescu OC, Venkateshiah SB, Kavuru MS, McCarthy K, Stoller JK. Estimating FVC from FEV2 and FEV3: assessment of a surrogate spirometric parameter. Chest. 2005;128(3):1274–1281. doi:10.1378/chest.128.3.127416162718
- Lam DC, Fong DY, Yu WC, et al. FEV3, FEV6 and their derivatives for detecting airflow obstruction in adult Chinese. Int J Tuberc Lung Dis. 2012;16(5):681–686. doi:10.5588/ijtld.11.0044-e22507932
- Sharafkhaneh A, Babb TG, Officer TM, Hanania NA, Sharafkhaneh H, Boriek AM. The confounding effects of thoracic gas compression on measurement of acute bronchodilator response. Am J Respir Crit Care Med. 2007;175(4):330–335. doi:10.1164/rccm.200701-094ED17110648
- Riccardo P, Emanuele C, Alessandro G, et al. Severity grading of chronic obstructive pulmonary disease: the confounding effect of phenotype and thoracic gas compression. J Appl Physiol 2015;118(7):796–802. doi:10.1152/japplphysiol.00801.2014
- O’Donnell DE, Forkert L, Webb KA. Evaluation of bronchodilator responses in patients with “irreversible” emphysema. Eur Respir J 2001;18(6):914–920. doi: 10.1183/09031936.01.00216501
- Rodriguez-Carballeira M, Heredia JL, Rue M, Quintana S, Almagro P. The bronchodilator test in chronic obstructive pulmonary disease: interpretation methods. Respir Med. 2007;101(1):34–42. doi:10.1016/j.rmed.2006.04.01816762537
- Omata M, Wakabayashi R, Kudoh S, Kida K. Correlation between bronchodilator responsiveness and quality of life in chronic obstructive pulmonary disease. Allergol Int. 2007;56(1):15–22. doi:10.2332/allergolint.O-06-43117259805
- Hankinson JL, Crapo RO, Jensen RL. Spirometric reference values for the 6-s FVC maneuver. Chest. 2003;124(5):1805–1811. doi:10.1378/chest.124.5.180514605052
- O’Donnell DE. Is sustained pharmacologic lung volume reduction now possible in COPD? Chest. 2006;129(3):501–503. doi:10.1378/chest.129.3.50116537841
- Pan MM, Zhang HS, Sun TY. Value of forced expiratory volume in 6 seconds (FEV6) in the evaluation of pulmonary function in Chinese elderly males. Zhonghua Yi Xue Za Zhi. 2017;97(20):1556–1561. doi:10.3760/cma.j.issn.0376-2491.2017.23.01228592061